The VectraplexECG System has been proven to detect ECG changes suggestive of a heart attack. Utilizing this, healthcare professionals are able to provide potentially faster treatment to the patient in order to prevent further health complications.
Hiawatha, IA (PRWEB) February 28, 2013
MobileDemand, a global provider of rugged tablet PC systems, and VectraCor, Inc., an emerging medical device company for cardiovascular solutions, have partnered to provide a turnkey solution to the healthcare industry for patients presenting with chest pain to detect real-time ECG changes suggestive of a heart attack. VectraCor has chosen the xTablet C1200 rugged convertible to use as their mobile, rugged version of the VectraplexECG System.
The high-performance xTablet C1200 is designed for the always-mobile professional who needs superior connectivity, reliability and access to business applications anytime, anywhere including hospital emergency departments and emergency medical services/ambulances. This durable laptop meets MIL-STD 810G requirements and is tested to survive drops from 4 feet. A special spill-resistant design protects the keyboard, touchpad, speakers, wireless and power switches, and all ports are dust resistant.
When the American College of Cardiology (ACC) meets on Saturday, March 9th in San Francisco, VectraCor will be displaying (Booth N5518) the VectraplexECG System with VectraplexAMI. This is the only 'stand-alone' cardiac monitor/ECG machine with a Cardiac Electrical Biomarker™ (CEB™) for the real-time detection of ECG changes that may be indicative of a heart attack (Acute Myocardial Infarction/AMI) plus the capability to derive a 15-lead ECG (12-lead plus XYZ leads and vector loops) for the US market and 22-lead ECG (12-lead plus right heart, posterior, XYZ leads and vector loops) for the European Market using only 5 electrodes.
“In the healthcare industry, fractions of seconds can mean the difference between life and death,” said Bob Zink, Vice President of Sales and Marketing at MobileDemand. “The VectraplexECG System has been proven to detect ECG changes suggestive of a heart attack. Utilizing this, healthcare professionals are able to provide potentially faster treatment to the patient in order to prevent further health complications.”
The potential to save more lives with this system is unparalleled as the immediate results allow for potentially faster treatment which may protect the heart muscle from further damage, thus potentially improving a patient's quality of life after a heart attack.
“The C1200 from MobileDemand is an ideal rugged and compact system that utilizes VectraCor’s proprietary technology to derive 15-leads of data and continuously monitor chest pain patients for ECG changes suggestive of an AMI,” says Brad Schreck, President and CEO of VectraCor.
MobileDemand is the nation’s leading provider of rugged tablet PC systems used in the transportation industry to improve productivity, anywhere. MobileDemand xTablets are used by mobile workers in many other industries including Healthcare, Agriculture, Food and Beverage Distribution, Manufacturing, Retail, Field Service, Military and Public Sector to cut operational costs and improve customer service. MobileDemand xTablet Rugged Tablet PCs and accessories are built military rugged to withstand harsh environments. They deliver the power, reliable performance and long-term savings companies need to achieve greater efficiency and productivity in the field. In 2012 MobileDemand earned the position of 1,034 on the 2012 Inc. 500/5000 list of the nation’s fastest growing private companies. The company has built its success on a commitment to innovation everywhere – in product design, customer relationships and in its channel. President Matt Miller also received recognition as a finalist for the prestigious 2012 Ernst & Young Entrepreneur of the Year award. MobileDemand. Innovation everywhere. Productivity anywhere. Additional information is available at http://www.RuggedTabletPC.com.
VectraCor is a medical device company located in Totowa, NJ with a disruptive and patented technology in the cardiovascular and emergency medicine markets. Cardiovascular disease is the #1 disease and killer in the US and World. The VectraCor technology has the potential to be the new standard of care in cardiac monitoring and the company aims to be a leader in cardiovascular solutions with a focus in Mobile Health (mHealth). VectraCor plans to incorporate their patented technology in other configurations to meet the growing needs of the healthcare environment. For more information please visit VectraCor at http://www.vectracor.com or contact Brad S. Schreck at 973-904-0444 or email bschreck(at)vectracor(dot)com.